Innovative Diagnosis and Therapeutic Modalities: Engineered Exosomes in Autoimmune Disease
Yuli Ji,Liangyu Mi,Miaomiao Zhao,Xiaoyao He,Yuting Hu,Yanan Gao,Chengliang Yin,Ke Xu
DOI: https://doi.org/10.2147/ijn.s452184
IF: 7.033
2024-05-02
International Journal of Nanomedicine
Abstract:Yuli Ji, 1, 2, &ast Liangyu Mi, 1, 2, &ast Miaomiao Zhao, 1, 2 Xiaoyao He, 1, 2 Yuting Hu, 1, 2 Yanan Gao, 1, 2 Chengliang Yin, 3 Ke Xu 1, 2 1 Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, People's Republic of China; 2 Department of Rheumatology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, People's Republic of China; 3 Faculty of Medicine, Macau University of Science and Technology, Macau, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ke Xu, Department of Rheumatology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, No. 99 Longcheng Street, Taiyuan, Shanxi Province, People's Republic of China, Email Autoimmune diseases refer to a group of conditions where the immune system produces an immune response against self-antigens, resulting in tissue damage. These diseases have profound impacts on the health of patients. In recent years, with the rapid development in the field of biomedicine, engineered exosomes have emerged as a noteworthy class of biogenic nanoparticles. By precisely manipulating the cargo and surface markers of exosomes, engineered exosomes have gained enhanced anti-inflammatory, immunomodulatory, and tissue reparative abilities, providing new prospects for the treatment of autoimmune diseases. Engineered exosomes not only facilitate the efficient delivery of bioactive molecules including nucleic acids, proteins, and cytokines, but also possess the capability to modulate immune cell functions, suppress inflammation, and restore immune homeostasis. This review mainly focuses on the applications of engineered exosomes in several typical autoimmune diseases. Additionally, this article comprehensively summarizes the current approaches for modification and engineering of exosomes and outlines their prospects in clinical applications. In conclusion, engineered exosomes, as an innovative therapeutic approach, hold promise for the management of autoimmune diseases. However, while significant progress has been made, further rigorous research is still needed to address the challenges that engineered exosomes may encounter in the therapeutic intervention process, in order to facilitate their successful translation into clinical practice and ultimately benefit a broader population of patients. Keywords: engineered exosomes, autoimmune diseases, genetic engineering, anti-inflammatory applications Autoimmune diseases primarily refer to a group of conditions in which the immune system's abnormal response and dysfunction lead to the attack on tissues and organs, causing damage to the body. They are one of the main contributors to the increasing mortality rates of chronic diseases. Relevant statistics indicate that the prevalence of autoimmune diseases is steadily rising, but the underlying mechanisms of these diseases remain partially unclear. This significantly hinders the prevention and diagnosis of autoimmune diseases. 1 Furthermore, the treatment of such diseases often involves symptomatic management and the use of immunosuppressants. However, these treatment approaches have limitations, and long-term use of immunosuppressants can increase the risk of infections and malignancies, significantly impacting the prognosis of patients. Researchers have been striving to explore new diagnostic biomarkers and treatment methods for autoimmune diseases. The emergence of exosomes and engineered exosomes offers hope in achieving this goal, particularly in the areas of treatment and drug delivery. They have the potential to partially address the shortcomings of existing treatment approaches. 2 Exosomes are a type of extracellular vesicles (EVs), which are lipid bilayer membrane-bound vesicles released by cells into the extracellular space during quiescence or under stress conditions. 3 Exosomes are composed of a diverse array of substances, exhibiting a wide range of biological functions. Exosomes achieve their anti-inflammatory effects through various complex mechanisms, including the secretion of anti-inflammatory proteins and cytokines, regulation of gene expression, modulation of immune cell function, and clearance of cellular debris as well as alleviation of oxidative stress. By encapsulating anti-inflammatory proteins and cytokines such as interleukin 10 (IL-10) and transforming growth factor-β (TGF-β), exosomes can intervene in the activity of imm -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology